NeuroXTek – The Swedish Neurotechnology Alliance
Short description
NeuroXTek is a national initiative to unite Sweden’s leading researchers, clinicians, and innovators around a shared vision for advancing brain health with neurotechnology. We have received 1.2 million SEK from the Swedish Research Council to build the foundation for a full-scale excellence cluster proposal, which will be submitted in March 2026.
Current vision
Sweden will be a global leader in brain health and mental wellbeing by 2035, driven by a unique cluster of evidence-based, accessible, innovative, and cutting-edge neurotechnologies. These tools—spanning sensing, imaging, stimulation, monitoring, analysis, and modeling—will support research, clinical practice, and home use.
Background
Poor mental and brain health are a leading cause of disability, threatening healthcare system and brain economy sustainability. Advancements in neurotechnologies enable improved precision, personalization, quality, scalability, and accessibility. Sweden has strong R&D in neuroscience, physics, engineering, and digital health, but fragmentation and regulatory changes hinder impact. A national initiative is needed to coordinate stakeholders and jointly accelerate transformative solutions.
Network application
Are you interested in shaping the future of neurotech through interdisciplinary collaboration, strategic workshops, and stakeholder engagement? We are looking for expertise in neuroscience, imaging, interfaces, modeling, ethics, social sciences and humanities, or innovation.
Apply to become part of the network:
NeuroXTek Network Registration
Our Network
Alliance members (as of December 18, 2025):
- 157 experts from...
- 18 organizations: Universities, R&D institutes, hospitals/regions,
SMEs, and large enterprises
Experts' Primary Fields
Thematic working groups
- Neuroscience Needs & Ethics: Understanding brain health and research challenges, ethical frameworks, societal relevance, and responsible innovation.
Leader: Suzanne Dickson, suzanne.dickson@neuro.gu.se - Neuroimaging & Sensing Technologies: Development and integration of sensing and imaging modalities such as MRI, MEG, fNIRS, and advanced data acquisition systems.
Leader: Daniel Lundqvist, daniel.lundqvist@ki.se - Clinical Needs & Regulatory Challenges: Clinical and patient needs, translation and innovation processes, regulatory compliance (e.g., MDR, AI Act), and integration into healthcare workflows.
Leader: Isabella Björkman-Burtscher, isabella.bjorkman-burtscher@gu.se> - Quantum & Disruptive Technologies: Quantum and other next-gen sensing, photonics, and emerging modalities and platforms for brain research and clinical applications.
Leaders: Mohamed Bourennane, boure@fysik.su.se and
Erik Aurell, eaurell@kth.se - Modeling, Compute, & AI: Computational neuroscience, digital twins, machine learning, simulation of brain systems, and brain-inspired computing.
Leader: William Hedley Thompson, william.thompson@ait.gu.se - Neurointerfaces & Materials: Bioelectronics, implantable devices, materials science, and neural interface technologies.
Leader: Maria Asplund, maria.asplund@chalmers.se - Molecular, Spectroscopic & Biomarker Technologies: Biomarker discovery, spectroscopy, molecular sensing, and translational neurobiology.
Leader: Jerker Widengren, jwideng@kth.se
Steering Committee